Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

18.8%

3 terminated/withdrawn out of 16 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

31%

5 trials in Phase 3/4

Results Transparency

67%

6 of 9 completed trials have results

Key Signals

1 recruiting6 with results

Enrollment Performance

Analytics

N/A

8(61.5%)

Phase 3

3(23.1%)

Phase 4

2(15.4%)

13Total

N/A(8)

Phase 3(3)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials

NCT07276282Phase 3Recruiting

Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction

Role: lead

NCT04854070Not ApplicableActive Not Recruiting

Intravascular Ultrasound Guidance for Complex High-risk Indicated Procedures

Role: lead

NCT04111770Not ApplicableCompleted

The OPTIMAL Randomized Controlled Trial

Role: lead

NCT03508219Not ApplicableTerminated

POLish Bifurcation Optimal Treatment Strategy Study for Left Main Bifurcation Percutaneous Coronary Intervention (PCI)

Role: lead

NCT06625801Not Yet Recruiting

IVUS CHIP UPP Registry

Role: lead

NCT04931771Not ApplicableUnknown

Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR Guided Revascularization

Role: lead

NCT02385279Not ApplicableCompleted

Study Comparing the MiStent SES Versus the XIENCE EES Stent

Role: lead

NCT02015832Completed

Trial Evaluating New Strategy in the Functional Assessment of 3-vessel Disease Using SYNTAXII Score in Patients With PCI

Role: lead

NCT01813435Phase 3Completed

GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation

Role: lead

NCT03023020Not ApplicableCompleted

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen

Role: lead

NCT02870140Not ApplicableCompleted

Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent

Role: lead

NCT02833948Phase 3Completed

Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)

Role: lead

NCT03851263Phase 4Withdrawn

Multislice Computed Tomography Assessment of PCSK9 Inhibition on Coronary Perfusion

Role: lead

NCT03851276Phase 4Withdrawn

A Multicentre, Pilot Study to Evaluate the Safety and the Feasibility of Planning and Execution of Surgical Revascularization in Patients With Complex Coronary Artery Disease, Based Solely on MSCT Imaging Utilizing GE Healthcare Revolution CT and HeartFlow FFRCT.

Role: lead

NCT02813473Completed

SYNTAX III REVOLUTION Trial: A Randomized Study Investigating the Use of CT Scan and Angiography of the Heart to Help the Doctors Decide Which Method is the Best to Improve Blood Supply to the Heart in Patients With Complex Coronary Artery Disease

Role: lead

NCT01986803Not ApplicableCompleted

ABSORB STEMI: the TROFI II Study

Role: lead

All 16 trials loaded